PerkinElmer chief scientist Marshak to lead China operations

By Mass High Tech Staff

PerkinElmer, Korean university join in drug research [March 17, 2009]

New England closer to opening first public cord blood bank [February 13, 2009]

ImmunoGen taps former Elixir CFO Perry for same role [January 9, 2009]

Northern Power taps Codon exec Danner as new CEO [December 10, 2008]

Daniel Marshak, senior vice president and chief scientific officer at PerkinElmer Inc., has added a third position, president of Greater China operations, to his role at the company. Based in Shanghai, Marshak will be responsible for leading new product development and overall operations in the Asia-Pacific region.

PerkinElmer (NYSE:PKI), a global provider of health sciences and photonics products, opened a 7,000 square foot technical center in Shanghai in 2007 and employs 1,200 people throughout seven Asia-Pacific cities. Worldwide, Waltham-based PerkinElmer employs 9,100 workers and reported 2007 net income of $131.7 million on revenue of $1.8 billion.

Earlier this month, PerkinElmer announced that it formed the ViaCord Research Institute, which will focus on using umbilical cord blood-derived stem cells for cord blood technologies, emerging stem cell therapies, genetic screening, product development and related transplants.

In March, the company announced the opening of a research and development center in Singapore for drug discovery and development, environmental monitoring, food safety and sustainable energy.

Comments

If you are commenting using a Facebook account, your profile information may be displayed with your comment depending on your privacy settings. By leaving the 'Post to Facebook' box selected, your comment will be published to your Facebook profile in addition to the space below.